Spyre Therapeutics, Inc. (SYRE) Earnings
NASDAQ·Healthcare·Biotechnology
$90.75
+2.29%
Mkt Cap $7.73B
EPS — Estimate vs Actual
Mkt Cap
$7.73B
P/E
—
Fwd P/E
—
P/S
85.39
Rev TTM
—
EPS TTM
-$2.19
NASDAQ·Healthcare·Biotechnology
$90.75
+2.29%
Mkt Cap $7.73B
Mkt Cap
$7.73B
P/E
—
Fwd P/E
—
P/S
85.39
Rev TTM
—
EPS TTM
-$2.19